First Human Embryos Edited in U.S.

Friday, 28th July 2017, 09:22
571 0

Researchers have demonstrated they can efficiently improve the DNA of human embryos. 

by Steve Connor  July 26, 2017


          
A still from a video shows gene-editing chemicals being injected into  a human egg at the moment of fertilization. Scientists used the  technique to correct DNA errors present in the father’s sperm. 
OSHU 


The first known attempt at creating genetically modified human  embryos in the United States has been carried out by a team of  researchers in Portland, Oregon, MIT Technology Review has learned.

The effort, led by Shoukhrat Mitalipov of Oregon Health and Science  University, involved changing the DNA of a large number of one-cell  embryos with the gene-editing technique CRISPR, according to people familiar with the scientific results.

Until now, American scientists have watched with a combination of  awe, envy, and some alarm as scientists elsewhere were first to explore  the controversial practice. To date, three previous reports of editing  human embryos were all published by scientists in China.

Now Mitalipov is believed to have broken new ground both in the  number of embryos experimented upon and by demonstrating that it is  possible to safely and efficiently correct defective genes that cause inherited diseases.

Although none of the embryos were allowed to develop for more than a  few days—and there was never any intention of implanting them into a  womb—the experiments are a milestone on what may prove to be an  inevitable journey toward the birth of the first genetically modified  humans.

In altering the DNA code of human embryos, the objective of  scientists is to show that they can eradicate or correct genes that  cause inherited disease, like the blood condition beta-thalassemia. The  process is termed “germline engineering”  because any genetically modified child would then pass the changes on  to subsequent generations via their own germ cells—the egg and sperm.

Some critics say germline experiments could open the floodgates to a  brave new world of “designer babies” engineered with genetic  enhancements—a prospect bitterly opposed by a range of religious organizations, civil society groups, and biotech companies.

The U.S. intelligence community last year called CRISPR a potential "weapon of mass destruction.”

          
 Shoukhrat Mitalipov is the first U.S.-based scientist known to have edited the DNA of human embryos.  
OHSU/Kristyna Wentz-Graff


Reached by Skype, Mitalipov declined to comment on the results,  which he said are pending publication. But other scientists confirmed  the editing of embryos using CRISPR. “So far as I know this will be the first study reported in the U.S.,” says Jun Wu, a collaborator at the  Salk Institute, in La Jolla, California, who played a role in the  project.

Better technique

The earlier Chinese publications, although limited in scope, found  CRISPR caused editing errors and that the desired DNA changes were taken  up not by all the cells of an embryo, only some. That effect, called  mosaicism, lent weight to arguments that germline editing would be an  unsafe way to create a person.

But Mitalipov and his colleagues are said to have convincingly  shown that it is possible to avoid both mosaicism and “off-target”  effects, as the CRISPR errors are known. 

A person familiar with the research says “many tens” of human IVF  embryos were created for the experiment using the donated sperm of men  carrying inherited disease mutations. Embryos at this stage are tiny  clumps of cells invisible to the naked eye. MIT Technology Review could not determine which disease genes had been chosen for editing.

“It is proof of principle that it can work. They significantly  reduced mosaicism. I don’t think it’s the start of clinical trials yet,  but it does take it further than anyone has before,” said a scientist  familiar with the project. 

Mitalipov’s group appears to have overcome earlier difficulties by  “getting in early” and injecting CRISPR into the eggs at the same time  they were fertilized with sperm.

That concept is similar to one tested in mice by Tony Perry of Bath  University. Perry successfully edited the mouse gene for coat color,  changing the fur of the offspring from the expected brown to white.

Somewhat prophetically, Perry’s paper on the research, published at  the end of 2014, said, “This or analogous approaches may one day enable  human genome targeting or editing during very early development.”

Genetic enhancement

Born in Kazakhstan when it was part of the former Soviet Union,  Mitalipov has for years pushed scientific boundaries. In 2007, he  unveiled the world’s first cloned monkeys. Then, in 2013, he created  human embryos through cloning, as a way of creating patient-specific  stem cells.

His team’s move into embryo editing coincides with a report by the U.S. National Academy of Sciences in February that was widely seen as providing a green light for lab research on germline modification.

The report also offered qualified support for the use of CRISPR for  making gene-edited babies, but only if it were deployed for the  elimination of serious diseases.

The advisory committee drew a red line at genetic enhancements—like  higher intelligence. “Genome editing to enhance traits or abilities  beyond ordinary health raises concerns about whether the benefits can  outweigh the risks, and about fairness if available only to some  people,” said Alta Charo, co-chair of the NAS’s study committee and  professor of law and bioethics at the University of Wisconsin–Madison.

In the U.S., any effort to turn an edited IVF embryo into a baby  has been blocked by Congress, which added language to the Department of  Health and Human Services funding bill forbidding it from approving  clinical trials of the concept.

Despite such barriers, the creation of a gene-edited person could  be attempted at any moment, including by IVF clinics operating  facilities in countries where there are no such legal restrictions.


Steve Connor is a freelance journalist based in the U.K.